TCRCure   Report issue

For profit Phase 1 Phase 2
Founded: Beijing China (2016)

Organization Overview

First Clinical Trial
2018
NCT03578406
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Guangdong TCRCure Biopharma Technology Co., Ltd | TCRCure Biopharma Corporation | TCRCure Biopharma Ltd | TCRCURE BIOPHARMA LTD.CHONGQING | TCRCure Biotech Co., Ltd